Clin2
NCT07240389Possibly a fitNot yet recruiting

Comparing three treatments for vulvar lichen sclerosus

Vulvar Lichen Sclerosus

Part of Women’s health & pregnancy clinical trials.

This study compares three different treatments for vulvar lichen sclerosus (a skin condition that can cause itching and pain in the vulvar area): a steroid ointment, a calcineurin inhibitor ointment, and platelet-rich plasma (PRP) therapy. It aims to see which treatment works best to relieve symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
45 people
Ages
30 years to 80 years
Study type
Interventional

Who can take part

  • You are between 30 and 80 years old.
  • You have been diagnosed with vulvar lichen sclerosus, confirmed by a biopsy.
  • You have not had any prior treatment for this condition.
  • You have no history of vulvar cancer or precancerous changes.
  • You are willing to come back for check-ups at 3 and 6 months and fill out questionnaires.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07363733Recruiting
Comparing radiofrequency vs steroid cream for vulvar lichen sclerosus

This study compares a new non-invasive treatment using radiofrequency energy to a standard steroid cream for women with vulvar lichen sclerosus. The goal is to see which works better for symptom relief.

Moscow
NCT07240519Recruiting
Comparing clobetasol cream vs CO2 laser for vulvar lichen sclerosus

This study compares two treatments—clobetasol steroid cream or a fractional CO2 laser—for women with vulvar lichen sclerosus who have not used steroid cream before. It looks at how inflammation changes after treatment.

Rio de Janeiro, Rio de Janeiro
NCT06662942Recruiting· Phase 1
Testing StrataMGT for vulvar lichen sclerosus symptoms

This study tests whether a new topical treatment, StrataMGT, can reduce symptoms of vulvar lichen sclerosus. It is for women with moderate to severe symptoms who are already using a stable topical prescription.

Washington D.C., District of Columbia
NCT07352917Recruiting· Phase 2
Methotrexate for severe vulvar lichen sclerosus

This study tests the drug methotrexate as a treatment for severe vulvar lichen sclerosus that has not responded to strong steroid creams. It aims to see if methotrexate can reduce symptoms and prevent further scarring.

São José dos Campos, São Paulo
NCT07450625Not yet recruiting
Collagen supplement for vulvar dryness in lichen sclerosus

This study tests whether a supplement called Collagendep (which contains collagen and hyaluronic acid) can help reduce dryness in women with lichen sclerosus who are also having a fat grafting procedure. It aims to see if adding this supplement improves symptoms compared to the fat grafting alone.

NCT07278999Recruiting
Light therapy and clobetasol for oral lichen planus

This trial tests two light-based treatments (photobiomodulation and photodynamic therapy) and a steroid cream (clobetasol) for painful oral lichen planus. The goal is to see which treatment works best to reduce mouth sores and discomfort.

Zabrze, Silesian Voivodeship

Hear when a new Vulvar Lichen Sclerosus trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.